Interaction Checker

Interactions with E/C/F/TAF (Genvoya)

Tuesday 01 December 2015

The web and app versions of the interaction charts have been updated to include Genvoya®, a single tablet regimen containing elvitegravir, cobicistat, emtricitabine (FTC) and tenofovir alafenamide. Interactions are listed under the abbreviation E/C/F/TAF and the combination is currently classified as an integrase inhibitor.
We are preparing updated records for elvitegravir/cobicistat to reflect fully its administration as a single tablet regimen with emtricitabine and tenofovir-DF (Stribild®). Once this has been completed, the printable charts will be updated with these changes.
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo viiv Sponsor logo abbvie Sponsor logo bristol myers squibb
Bhiva Glasgow Eacs logo 2014 Basel text